Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001186607 | SCV001353084 | likely benign | Cardiomyopathy | 2019-09-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002559941 | SCV001663819 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-08-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002375089 | SCV002687176 | likely benign | Cardiovascular phenotype | 2020-01-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004008617 | SCV004821620 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538417 | SCV004716161 | likely benign | RYR2-related disorder | 2022-09-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |